The Prevalence and Effects of Adult Attention-deficit/hyperactivity Disorder (ADHD) on the Performance of Workers: Results from the WHO World Mental Health Survey Initiative
Overview
Occupational Medicine
Authors
Affiliations
Objectives: To estimate the prevalence and workplace consequences of adult attention-deficit/hyperactivity disorder (ADHD).
Methods: An ADHD screen was administered to 18-44-year-old respondents in 10 national surveys in the WHO World Mental Health (WMH) Survey Initiative (n = 7075 in paid or self-employment; response rate 45.9-87.7% across countries). Blinded clinical reappraisal interviews were administered in the USA to calibrate the screen. Days out of role were measured using the WHO Disability Assessment Schedule (WHO-DAS). Questions were also asked about ADHD treatment.
Results: An average of 3.5% of workers in the 10 countries were estimated to meet DSM-IV criteria for adult ADHD (inter-quartile range: 1.3-4.9%). ADHD was more common among males than females and less common among professionals than other workers. ADHD was associated with a statistically significant 22.1 annual days of excess lost role performance compared to otherwise similar respondents without ADHD. No difference in the magnitude of this effect was found by occupation, education, age, gender or partner status. This effect was most pronounced in Colombia, Italy, Lebanon and the USA. Although only a small minority of workers with ADHD ever received treatment for this condition, higher proportions were treated for comorbid mental/substance disorders.
Conclusions: ADHD is a relatively common condition among working people in the countries studied and is associated with high work impairment in these countries. This impairment, in conjunction with the low treatment rate and the availability of cost-effective therapies, suggests that ADHD would be a good candidate for targeted workplace screening and treatment programs.
Di Lorenzo R, Latella E, Gualtieri F, Adriani A, Ferri P, Filippini T Healthcare (Basel). 2025; 13(3).
PMID: 39942433 PMC: 11816683. DOI: 10.3390/healthcare13030244.
Digital assessments for children and adolescents with ADHD: a scoping review.
Cibrian F, Monteiro E, Lakes K Front Digit Health. 2024; 6:1440701.
PMID: 39439849 PMC: 11493775. DOI: 10.3389/fdgth.2024.1440701.
Beslot A, Grall-Bronnec M, Balem M, Schreck B, Laforgue E, Victorri-Vigneau C Harm Reduct J. 2024; 21(1):165.
PMID: 39252018 PMC: 11382469. DOI: 10.1186/s12954-024-01079-7.
Baweja R, Faraone S, Childress A, Weiss M, Loo S, Wilens T J Child Adolesc Psychopharmacol. 2024; 34(4):167-182.
PMID: 38686563 PMC: 11302246. DOI: 10.1089/cap.2024.0022.
Sluggish Cognitive Tempo as a Transdiagnostic Link Between Adult ADHD and Internalizing Symptoms.
Kamradt J, Eadeh H, Nikolas M J Psychopathol Behav Assess. 2024; 44(3):699-712.
PMID: 38221987 PMC: 10786088. DOI: 10.1007/s10862-021-09926-8.